Updated:
OneHealth Ventures
OneHealth Ventures is a venture capital firm headquartered in London, United Kingdom. The firm operates within the life sciences sector, focusing on specific...
OneHealth Ventures
OneHealth Ventures is a venture capital firm headquartered in London, United Kingdom. The firm operates within the life sciences sector, focusing on specific medical research initiatives. Specifically, OneHealth Ventures researches epsilon toxin in the context of multiple sclerosis. In addition to this research, the firm develops vaccines against ETX. Further details regarding its broader investment strategy, targeted stages, and total assets under management are not specified in the available facts. The firm maintains a digital presence through its website at onehealthventures.com. Its activities reflect a combination of venture capital investment and direct medical research development.
General information
Firm type
Venture Capital
Location
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Sector focus
Frequently asked questions
Where is OneHealth Ventures headquartered?
OneHealth Ventures is headquartered in London, United Kingdom.
What specific medical research does OneHealth Ventures focus on?
OneHealth Ventures researches epsilon toxin in multiple sclerosis and develops vaccines against ETX.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: